Primary myelofibrosis

A rare myeloproliferative neoplasm characterized by stem-cell derived clonal over proliferation of mature myeloid lineages, such as erythrocytes, leukocytes, and megakaryocytes, with variable degrees of megakaryocyte atypia, associated with reticulin and/or collagen bone marrow fibrosis, osteosclerosis, ineffective erythropoiesis, angiogenesis, extramedullary hematopoiesis, and abnormal cytokine expression.

Pericardial effusion

Accumulation of fluid within the pericardium.


Total: 3

                       


(per page)
PMID (PMCID)
2266403
 MALE
Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion.
Sprengelmeyer JT, McDermott RL.
J Nucl Med. 1990;31(12):2034-6.
A 68-yr-old male with agnogenic myeloid metaplasia was given phosphorus-32-colloidal chromic phosphate intrapericardially for the treatment of malignant pericardial effusion.
2769970
 FEMALE
[The use of MCNU to a patient of primary myelofibrosis complicated with pericardial effusion and proteinuria].
Shiga Y, Matsuoka R, Abe R, Matsuda S, Uchida T, Kariyone S.
Rinsho Ketsueki. 1989;30(4):497-501.
[The use of MCNU to a patient of primary myelofibrosis complicated with pericardial effusion and proteinuria].
3954534
 MIXED_SAMPLE Middle Aged
Postsplenectomy pericardial effusion in two patients with myeloid metaplasia.
Nagler A, Brenner B, Argov S, Tatarsky I.
Arch Intern Med. 1986;146(3):600-1.
We describe two patients with agnogenic myeloid metaplasia and refractory hemolytic anemia in whom pericardial effusion appeared a few days after splenectomy.